Aspects of defibrillator therapy in congestive heart failure;Aktuelle aspekte der defibrillatortherapie bei herzinsuffizienz

Zeitschrift fur Kardiologie

Volumn 90, Issue SUPPL. 1, 2001, Pages

  Trappe, H J ^a   Meine, M ^a   Pfitzner, P ^a   Voigt, B ^a   Weismuller P ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Cardioverter defibrillator; Heart failure; ICD discharges; Sudden death prognosis

Indexed keywords

ADULT; AGED; ARTICLE; CAUSE OF DEATH; CONGESTIVE HEART FAILURE; DEFIBRILLATOR; DISEASE CLASSIFICATION; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE TACHYCARDIA; HUMAN; IMPLANT; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; SUDDEN DEATH; SURGICAL MORTALITY; SURVIVAL RATE; THORACOTOMY; TREATMENT OUTCOME;

AGED; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; SURVIVAL ANALYSIS; TIME FACTORS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0035109694     PISSN: 03005860     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003920170056     Document Type: Article

References (33)

1. A report of the American College of Cardiology/American Heart Association Task Force on Practical Guidelines (Committee on Pacemaler Implantation)
2. Is impaired intraventricular conduction delay associated with impaired exercise performance in ICD patients?
3. Performance characteristics of a novel coronary venous lead designed for left ventricular pacing
4. The pacing therapies for congestive heart failure (PATH-CHF) study: Rationale, design, and endpoints of a prospective randomized multicenter study
5. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary artery bypass graft surgery
6. Evaluation of different ventricular pacing sites in patients with severe heart failure. Results of an acute hemodynamic study
7. Evaluation of a new triple-wire coronary venous lead in the treatment of heart failure
8. Automatic internal cardioverter defibrillator: A bridge to heart transplantation
9. Role of ventricular tachycardia surgery and catheter ablation as complements or alternatives to the implantable cardioverter defibrillator in the 1990s
10. Actuarial risk of sudden death while awaiting cardiac transplantation in patients with atherosclerotic heart disease
11. Arrhythmogenic mortality in heart transplantation candidates
12. AICD benefit
13. Guidelines for implantation of automatic cardioverter/defibrillators
14. The implantable defibrillator: An electronic bridge to cardiac transplantation
15. Impact of biventricular pacing on all-cause mortality in a randomised crossover trial of heart failure patients with ventricular arrhythmias
16. Survival of patients with congestive heart failure: Past, present, and future prospects
17. Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings
18. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia
19. Sudden cardiac death: Epidemology, transient risk, and intervention assessment
20. Sudden cardiac death in persons with normal (or near normal) hearts
21. Clinical investigation of antiarrhythmic devices - A statement for healthcare professionals from a joint task force of the North American Society of Pacing and Electrophysiology, the American College of Cardiology, the American Heart Association, and the working group on arrhythmias and cardiac pacing of the European ociety of Cardiology
22. Sudden death prevention in patients with advanced ventricular dysfunction
23. Guidelines for the use of implantable cardioverter defibrillators
24. Nonpharmacological therapy of ventricular tachyarrhythmias: Observations in 554 patients
25. 10 Jahre therapie mit implantierbaren defibrillatoren - Eine beobachtung bei 353 patienten
26. Ursachen des akuten herz-kreislauf-stillstandes
27. Cardioverter-defibrillator implantation in the catherization laboratory: Initial experiences in 48 patients
28. Prognosis of patients with ventricular tachycardia and ventricular fibrillation
29. Identifikation des rhythmusgefährdeten patienten. Nichtinvasive und invasive diagnostik
30. Clinical results with implantable cardioverter-defibrillator therapy
31. Early and long-term results of catheter ablation in patients with incessant ventricular tachycardia
32. Cardioverter defibrillator therapy as a bridge to heart transplantation
33. New concepts of dual-chamber or biventricular pacing therapy in patients with life-threatening ventricular tachyarrhythmias